27-hydroxycholesterol has been researched along with desipramine in 2 studies
Studies (27-hydroxycholesterol) | Trials (27-hydroxycholesterol) | Recent Studies (post-2010) (27-hydroxycholesterol) | Studies (desipramine) | Trials (desipramine) | Recent Studies (post-2010) (desipramine) |
---|---|---|---|---|---|
345 | 11 | 214 | 5,775 | 487 | 414 |
Protein | Taxonomy | 27-hydroxycholesterol (IC50) | desipramine (IC50) |
---|---|---|---|
Solute carrier family 22 member 1 | Homo sapiens (human) | 9.18 | |
5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.35 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0003 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.35 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0034 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0003 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0003 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.35 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.0031 | |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 7.8 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.35 | |
5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | 0.35 | |
5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | 0.35 | |
5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.35 | |
5-hydroxytryptamine receptor 6 | Rattus norvegicus (Norway rat) | 0.35 | |
Histamine H1 receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.1961 | |
5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | 0.35 | |
5-hydroxytryptamine receptor 5A | Rattus norvegicus (Norway rat) | 0.35 | |
5-hydroxytryptamine receptor 5B | Rattus norvegicus (Norway rat) | 0.35 | |
5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.35 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0003 | |
Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | 3.8 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 9.9 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.4035 | |
Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 1.52 | |
5-hydroxytryptamine receptor 4 | Rattus norvegicus (Norway rat) | 0.35 | |
5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.35 | |
Solute carrier family 22 member 2 | Rattus norvegicus (Norway rat) | 10 | |
Transporter | Rattus norvegicus (Norway rat) | 7.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Band, MR; Hernandez, A; Kummerow, FA; Liu, ZL; Zhou, Q | 1 |
Dias, IH; Fell, S; Griffiths, HR; Lip, GY; Mistry, J; Polidori, MC; Reis, A; Spickett, CM | 1 |
2 other study(ies) available for 27-hydroxycholesterol and desipramine
Article | Year |
---|---|
27-Hydroxycholesterol inhibits neutral sphingomyelinase in cultured human endothelial cells.
Topics: Analysis of Variance; Carbon Radioisotopes; Cells, Cultured; Desipramine; DNA Primers; Endothelial Cells; Gene Expression Regulation, Enzymologic; Glutathione; Humans; Hydroxycholesterols; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spectrophotometry; Sphingomyelin Phosphodiesterase; Sphingomyelins | 2004 |
Oxidized LDL lipids increase β-amyloid production by SH-SY5Y cells through glutathione depletion and lipid raft formation.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Cell Line, Tumor; Cell Survival; Cholesterol, LDL; Desipramine; Enzyme Activation; Enzyme Inhibitors; Free Radical Scavengers; Glutathione; Glutathione Disulfide; Humans; Hydroxycholesterols; Lipid Metabolism; Lipoproteins, LDL; Membrane Microdomains; Oxidation-Reduction; Sphingomyelin Phosphodiesterase | 2014 |